Scientists peek inside the brain to see how migraine drug works
NCT ID NCT04271202
First seen Jan 26, 2026 · Last updated Jun 09, 2026 · Updated 16 times
Summary
This study looked at how galcanezumab, a newer migraine prevention drug, affects the brain. Researchers used MRI scans to measure changes in brain structure in 64 adults with chronic migraine. The goal was to learn whether the drug works inside or outside the brain, not to test if it cures or controls the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pain Clinic at Beth Israel Deaconess Medical Center
Brookline, Massachusetts, 02445, United States
Conditions
Explore the condition pages connected to this study.